• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

非肝硬化性门静脉高压症——诊断与管理。

Non-cirrhotic portal hypertension - diagnosis and management.

机构信息

Department of Pediatric Hepatology, Institute of Liver and Biliary Sciences, New Delhi, India.

Department of Hepatology, Institute of Liver and Biliary Sciences, New Delhi, India.

出版信息

J Hepatol. 2014 Feb;60(2):421-41. doi: 10.1016/j.jhep.2013.08.013. Epub 2013 Aug 23.

DOI:10.1016/j.jhep.2013.08.013
PMID:23978714
Abstract

NCPH is a heterogeneous group of liver disorders of vascular origin, leading to PHT with near normal HVPG. NCPF/IPH is a disorder of young adults or middle aged women, whereas EHPVO is a disorder of childhood. Early age acute or recurrent infections in an individual with thrombotic predisposition constitute the likely pathogenesis. Both disorders present with clinically significant PHT with preserved liver functions. Diagnosis is easy and can often be made clinically with support from imaging modalities. Management centers on control and prophylaxis of variceal bleeding. In EHPVO, there are additional concerns of growth faltering, portal biliopathy, MHE and parenchymal dysfunction. Surgical shunts are indicated in patients with failure of endotherapy, bleeding from sites not amenable to endotherapy, symptomatic hypersplenism or symptomatic biliopathy. Persistent growth failure, symptomatic and recurrent hepatic encephalopathy, impaired quality of life or massive splenomegaly that interferes with daily activities are other surgical indications. Rex-shunt or MLPVB is the recommended shunt for EHPVO, but needs proper pre-operative radiological assessment and surgical expertise. Both disorders have otherwise a fairly good prognosis, but need regular and careful surveillance. Hepatic schistosomiasis, CHF and NRH have similar presentation and comparable prognosis.

摘要

NCPH 是一组由血管来源引起的异质性肝脏疾病,导致 HVPG 接近正常的 PHT。NCPF/IPH 是年轻人或中年妇女的疾病,而 EHPVO 是儿童的疾病。具有血栓倾向的个体中早期急性或复发性感染构成了可能的发病机制。这两种疾病均表现为具有临床意义的 PHT 和保留的肝功能。诊断很容易,通常可以通过影像学手段进行临床诊断。治疗重点是控制和预防静脉曲张出血。在 EHPVO 中,还存在生长迟缓、门静脉胆病、MHE 和实质功能障碍等额外问题。对于内镜治疗失败、内镜治疗不可行部位出血、症状性脾功能亢进或症状性胆病的患者,需要进行手术分流。持续生长发育不良、症状性和复发性肝性脑病、生活质量受损或妨碍日常生活的巨大脾肿大是其他手术指征。Rex 分流或 MLPVB 是 EHPVO 的推荐分流术,但需要适当的术前影像学评估和手术专业知识。这两种疾病的预后都相当不错,但需要定期和仔细的监测。肝血吸虫病、CHF 和 NRH 的表现相似,预后相当。

相似文献

1
Non-cirrhotic portal hypertension - diagnosis and management.非肝硬化性门静脉高压症——诊断与管理。
J Hepatol. 2014 Feb;60(2):421-41. doi: 10.1016/j.jhep.2013.08.013. Epub 2013 Aug 23.
2
Idiopathic portal hypertension and extrahepatic portal venous obstruction.特发性门静脉高压症和肝外门静脉阻塞。
Hepatol Int. 2018 Feb;12(Suppl 1):148-167. doi: 10.1007/s12072-018-9844-3. Epub 2018 Feb 20.
3
Non-cirrhotic portal hypertension.非肝硬化性门静脉高压症
Clin Liver Dis. 2014 May;18(2):451-76. doi: 10.1016/j.cld.2014.01.009.
4
Noncirrhotic portal hypertension.非肝硬化性门静脉高压症
J Clin Exp Hepatol. 2011 Sep;1(2):94-108. doi: 10.1016/S0973-6883(11)60128-X. Epub 2011 Nov 9.
5
Noncirrhotic Portal Hypertension: Current and Emerging Perspectives.非肝硬化性门静脉高压:当前和新兴的观点。
Clin Liver Dis. 2019 Nov;23(4):781-807. doi: 10.1016/j.cld.2019.07.006.
6
Non-cirrhotic portal fibrosis: current concepts and management.非肝硬化性门脉纤维化:当前概念与管理
J Gastroenterol Hepatol. 2002 May;17(5):526-34. doi: 10.1046/j.1440-1746.2002.02764.x.
7
Non-cirrhotic portal hypertension versus idiopathic portal hypertension.非肝硬化性门静脉高压症与特发性门静脉高压症
J Gastroenterol Hepatol. 2002 Dec;17 Suppl 3:S204-13. doi: 10.1046/j.1440-1746.17.s3.2.x.
8
Non-cirrhotic portal fibrosis (idiopathic portal hypertension): experience with 151 patients and a review of the literature.非肝硬化性门脉纤维化(特发性门脉高压症):151例患者的经验及文献综述
J Gastroenterol Hepatol. 2002 Jan;17(1):6-16. doi: 10.1046/j.1440-1746.2002.02596.x.
9
Management of extra hepatic portal venous obstruction (EHPVO): current strategies.肝外门静脉阻塞(EHPVO)的管理:当前策略
Trop Gastroenterol. 2011 Apr-Jun;32(2):94-102.
10
Etiological spectrum of esophageal varices due to portal hypertension in Indian children: is it different from the West?印度儿童门静脉高压所致食管静脉曲张的病因谱:与西方有差异吗?
J Gastroenterol Hepatol. 2008 Sep;23(9):1354-7. doi: 10.1111/j.1440-1746.2007.05102.x. Epub 2007 Aug 6.

引用本文的文献

1
Cardiopulmonary changes and its association with clinical features in noncirrhotic portal hypertension.非肝硬化性门静脉高压症的心肺变化及其与临床特征的关联
World J Gastroenterol. 2025 Aug 14;31(30):109256. doi: 10.3748/wjg.v31.i30.109256.
2
Advances in portal pressure measurement: Endoscopic techniques, challenges, and implications for liver transplantation.门静脉压力测量的进展:内镜技术、挑战及其对肝移植的影响
World J Hepatol. 2025 Aug 27;17(8):107679. doi: 10.4254/wjh.v17.i8.107679.
3
Case Report: transjugular intrahepatic portosystemic shunt combined with hemodialysis for refractory ascites treatment in a patient with idiopathic non-cirrhotic portal hypertension and uremia.
病例报告:经颈静脉肝内门体分流术联合血液透析治疗特发性非肝硬化门静脉高压症合并尿毒症患者的顽固性腹水
Front Med (Lausanne). 2025 Jul 18;12:1607521. doi: 10.3389/fmed.2025.1607521. eCollection 2025.
4
Laparoscopic treatment for a rare case of giant spleen with splenic arteriovenous fistula and giant vein aneurysm: multidisciplinary management and case report.腹腔镜治疗罕见的巨大脾脏合并脾动静脉瘘及巨大静脉瘤:多学科管理与病例报告
J Surg Case Rep. 2025 Jul 17;2025(7):rjaf531. doi: 10.1093/jscr/rjaf531. eCollection 2025 Jul.
5
An 88-Year-Old Woman with a 33-Year History of Idiopathic Portal Hypertension Presenting with Hepatocellular Carcinoma Treated with Carbon-Ion Radiotherapy.一名患有特发性门静脉高压症33年的88岁女性,因肝细胞癌接受碳离子放疗。
Am J Case Rep. 2025 Jul 18;26:e947725. doi: 10.12659/AJCR.947725.
6
Chronic lymphocytic leukemia complicated by non-cirrhotic portal hypertension: an autopsy case report.慢性淋巴细胞白血病合并非肝硬化性门静脉高压症:一例尸检病例报告
Clin J Gastroenterol. 2025 Jul 16. doi: 10.1007/s12328-025-02184-1.
7
A novel prognostic model based on portal vein diameter for patients with acute-on-chronic liver failure.一种基于门静脉直径的新型慢性肝衰竭急性发作患者预后模型。
Sci Rep. 2025 May 26;15(1):18408. doi: 10.1038/s41598-025-03432-7.
8
Deadly intersection: Schistosomiasis, hepatopulmonary syndrome, and cirrhosis.致命交叉点:血吸虫病、肝肺综合征与肝硬化
World J Hepatol. 2025 Apr 27;17(4):105583. doi: 10.4254/wjh.v17.i4.105583.
9
Safety and efficacy of minimally invasive splenectomy with endotherapy for non-cirrhotic portal fibrosis: A retrospective cohort study.非肝硬化性门脉纤维化的微创脾切除术联合内镜治疗的安全性与疗效:一项回顾性队列研究
Ann Hepatobiliary Pancreat Surg. 2025 Aug 31;29(3):362-370. doi: 10.14701/ahbps.25-033. Epub 2025 Apr 29.
10
Nodular Regenerative Hyperplasia Is a Frequent Finding in Explanted Livers of Patients With Maple Syrup Urine Disease.结节性再生性增生在枫糖尿症患者的移植肝脏中很常见。
Pediatr Dev Pathol. 2025 Jul-Aug;28(4):273-280. doi: 10.1177/10935266251333007. Epub 2025 Apr 17.